AR118304A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES

Info

Publication number
AR118304A1
AR118304A1 ARP200100652A ARP200100652A AR118304A1 AR 118304 A1 AR118304 A1 AR 118304A1 AR P200100652 A ARP200100652 A AR P200100652A AR P200100652 A ARP200100652 A AR P200100652A AR 118304 A1 AR118304 A1 AR 118304A1
Authority
AR
Argentina
Prior art keywords
lingo
pharmaceutical compositions
antibodies
compositions containing
containing anti
Prior art date
Application number
ARP200100652A
Other languages
Spanish (es)
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of AR118304A1 publication Critical patent/AR118304A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan composiciones farmacéuticas que contienen anticuerpos anti-LINGO-1 o fragmentos de unión a LINGO-1 de estos. Estas composiciones farmacéuticas son útiles en el tratamiento de enfermedades desmielinizantes del SNC, tales como esclerosis múltiple y neuritis óptica (por ejemplo, neuritis óptica aguda).Pharmaceutical compositions containing anti-LINGO-1 antibodies or LINGO-1 binding fragments of these are provided. These pharmaceutical compositions are useful in the treatment of CNS demyelinating diseases, such as multiple sclerosis and optic neuritis (eg, acute optic neuritis).

ARP200100652A 2019-03-11 2020-03-10 PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES AR118304A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962816668P 2019-03-11 2019-03-11

Publications (1)

Publication Number Publication Date
AR118304A1 true AR118304A1 (en) 2021-09-29

Family

ID=78076139

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200100652A AR118304A1 (en) 2019-03-11 2020-03-10 PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES

Country Status (1)

Country Link
AR (1) AR118304A1 (en)

Similar Documents

Publication Publication Date Title
MX2020013853A (en) Novel compounds.
TR201901445T4 (en) Il2rbeta / common gamma chain antibodies.
BR112016029318A2 (en) myeloma treatment
CO2018006662A2 (en) Apeline receptor agonists and methods of use
DOP2017000047A (en) ANTI-LAG3 ANTIBODIES AND ANTIGEN UNION FRAGMENTS
UY36705A (en) 4-HYDROXI-3- (HETEROARIL) PIRIDIN-2-ONA COMPOUNDS AS APJ AGONISTS
PH12020550051A1 (en) Glp-1 compositions and uses thereof
UY37169A (en) ANALOGS OF 1,4-DIHYDROPIRIMIDIN-5-CARBOXAMIDS AS APJ AGONISTS AND COMPOSITIONS CONTAINING THEM
CO2017008824A2 (en) Bicyclic heterocycles as fgfr4 inhibitors
UY36949A (en) 2,4-DIHIDROXI-NICOTINAMIDS AS APJ AGONISTS
EA202090720A1 (en) GalNAc DERIVATIVES
MX2021014286A (en) Multispecific proteins.
CO2017011958A2 (en) Substituted benzamides and methods to use them
EA201892225A1 (en) ANTIBODIES TO THE COMPLEX Bb FACTOR AND THEIR APPLICATION
DOP2021000130A (en) HSD17B13 EXPRESSION MODULATORS
EA201890068A1 (en) PARTICLES OF DIMETHYLATE AND PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
MX2020007628A (en) Compositions and methods of use.
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
MX2018006773A (en) Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine.
WO2018189661A3 (en) Methods and compounds for treating diabetes
CO2021015998A2 (en) Materials and methods for modulating t-cell mediated immunity
PH12021551058A1 (en) Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof
MX2022015966A (en) Antibodies and methods for treating claudin-associated diseases.
UY38605A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES
AR118304A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES